These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 2943952

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Role of uridine phosphorylase for antitumor activity of 5'-deoxy-5-fluorouridine.
    Ishitsuka H, Miwa M, Takemoto K, Fukuoka K, Itoga A, Maruyama HB.
    Gan; 1980 Feb; 71(1):112-23. PubMed ID: 6445847
    [Abstract] [Full Text] [Related]

  • 3. Selectivity of action of 5-FU: biochemical basis.
    Rustum YM, Danhauser L, Wang G.
    Bull Cancer; 1979 Feb; 66(1):43-7. PubMed ID: 154352
    [Abstract] [Full Text] [Related]

  • 4. The therapeutic effects of orally administered 5'-deoxy-5-fluorouridine, 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil on experimental murine tumors.
    Uehara N, Baba H, Nitta K, Kunimoto T, Takeuchi M, Sasaki T, Tanaka T.
    Jpn J Cancer Res; 1985 Oct; 76(10):1034-41. PubMed ID: 2934356
    [Abstract] [Full Text] [Related]

  • 5. Biological activities of 5-fluorouracil and its prodrug 5'-deoxy-5-fluorouridine in rats.
    Au JL, Rustum YM, Slocum HK.
    Cancer Drug Deliv; 1987 Oct; 4(3):137-44. PubMed ID: 2967103
    [Abstract] [Full Text] [Related]

  • 6. Differential selectivity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in cultured human B lymphocytes and mouse L1210 leukemia.
    Au JL, Rustum YM, Minowada J, Srivastava BI.
    Biochem Pharmacol; 1983 Feb 01; 32(3):541-6. PubMed ID: 6221728
    [Abstract] [Full Text] [Related]

  • 7. Comparative antitumor activity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in combination with radiation therapy in mice bearing colon 26 adenocarcinoma.
    Ishikawa T, Tanaka Y, Ishitsuka H, Ohkawa T.
    Jpn J Cancer Res; 1989 Jun 01; 80(6):583-91. PubMed ID: 2527217
    [Abstract] [Full Text] [Related]

  • 8. Lack of contribution of dihydrofluorouracil and alpha-fluoro-beta-alanine to the cytotoxicity of 5'-deoxy-5-fluorouridine on human keratinocytes.
    Fischel JL, Formento P, Ciccolini J, Etienne-Grimaldi MC, Milano G.
    Anticancer Drugs; 2004 Nov 01; 15(10):969-74. PubMed ID: 15514566
    [Abstract] [Full Text] [Related]

  • 9. Antitumor activity of two novel low immunosuppressive fluoropyrimidines UK-21 and UK-25.
    Sakamoto O, Mori H, Kitaichi K, Koda A, Kato T.
    Jpn J Pharmacol; 1992 Aug 01; 59(4):469-76. PubMed ID: 1434142
    [Abstract] [Full Text] [Related]

  • 10. Effect of coadministration of thymine or thymidine on the antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil.
    Fujii S, Kitano S, Ikenaka K, Fukushima M, Nakamura H, Maehara Y, Shirasaka T.
    Gan; 1980 Feb 01; 71(1):100-6. PubMed ID: 6769735
    [Abstract] [Full Text] [Related]

  • 11. Effect of uridine coadministration on 5'-deoxy-5-fluorouridine disposition in rats.
    Au JL, Wientjes MG, Bramer SL.
    Cancer Chemother Pharmacol; 1988 Feb 01; 22(1):5-10. PubMed ID: 2969304
    [Abstract] [Full Text] [Related]

  • 12. Antitumor activity of a new fluoropyrimidine derivative, 5'-deoxy-5-fluorouridine, against murine and human experimental tumors.
    Fujimoto S, Wang Y, Inoue K, Ogawa M.
    Jpn J Cancer Res; 1985 Jul 01; 76(7):644-50. PubMed ID: 3161854
    [Abstract] [Full Text] [Related]

  • 13. [Comparative studies on the antitumor activity of the fluorinated pyrimidines 5'-DFUR, tegafur, UFT and FUra on various murine tumors].
    Miwa M, Eda H, Fukuda H, Fujimoto K, Ishitsuka H.
    Gan To Kagaku Ryoho; 1988 May 01; 15(5):1755-63. PubMed ID: 2967051
    [Abstract] [Full Text] [Related]

  • 14. [5'-Deoxy-5-fluorouridine enzymatic activation from the masked compound to 5-fluorouracil in human malignant tissues].
    Hara Y.
    Gan To Kagaku Ryoho; 1984 Oct 01; 11(10):2133-43. PubMed ID: 6237613
    [Abstract] [Full Text] [Related]

  • 15. Selection of therapeutic agents for intraocular proliferative disease. II. Differing antiproliferative activity of the fluoropyrimidines.
    Blumenkranz MS, Hartzer MK, Hajek AS.
    Arch Ophthalmol; 1987 Mar 01; 105(3):396-9. PubMed ID: 2950847
    [Abstract] [Full Text] [Related]

  • 16. Acyclothymidine alleviates intestinal toxicity of 5'-deoxy-5-fluorouridine without loss of antitumor activity in mice.
    Hamada A, Fukushima S, Saneyoshi M, Shimizu S, Kawaguchi T, Nakano M.
    Biol Pharm Bull; 1996 Oct 01; 19(10):1362-6. PubMed ID: 8913513
    [Abstract] [Full Text] [Related]

  • 17. Fluoropyrimidine treatment of ocular cicatricial disease.
    Heath TD, Lopez NG, Lewis GP, Stern WH.
    Invest Ophthalmol Vis Sci; 1986 Jun 01; 27(6):940-5. PubMed ID: 2940202
    [Abstract] [Full Text] [Related]

  • 18. Effect of deoxyuridine coadministration on toxicity and antitumor activity of fluorouracil and floxuridine.
    Jato JG, Lake LM, Grunden EE, Johnson BM.
    J Pharm Sci; 1975 Jun 01; 64(6):943-6. PubMed ID: 124347
    [Abstract] [Full Text] [Related]

  • 19. In vivo antitumor effects of fluoropyrimidines on colon adenocarcinoma 38 and enhancement by leucovorin.
    Iigo M, Nishikata K, Hoshi A.
    Jpn J Cancer Res; 1992 Apr 01; 83(4):392-6. PubMed ID: 1387127
    [Abstract] [Full Text] [Related]

  • 20. Fluorinated pyrimidines. XXIX. Syntheses of 2',3'-dehydro-5-fluoro-2'-deoxyuridine and 2',3'-dideoxy-5-fluorouridine.
    Khwaja TA, Heidelberger C.
    J Med Chem; 1967 Nov 01; 10(6):1066-70. PubMed ID: 4293494
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.